Patrick J. Christmas, SVP, General Counsel at REGENXBIO Inc. (RGNX), sold 9,280 shares at $46.79 ($440K) on 2018-12-18, disclosed to the SEC on 2018-12-20.
Open-market sale of $440k RGNX by SVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.79 | 2,225 | $104K | 23.7% |
| 2 | $46.79 | 2,225 | $104K | 23.7% |
| 3 | $47.85 | 2,055 | $98K | 22.3% |
| 4 | $47.85 | 2,055 | $98K | 22.3% |
| 5 | $48.97 | 720 | $35K | 8.0% |
| Total | $47.43 avg | 9,280 |
| $440K |
| 100% |
| Filing → |
| RGNX | SELL | 2021-02-04 | $873K | — | Filing → |
| RGNX | SELL | 2021-01-12 | $2.1M | — | Filing → |
| RGNX | SELL | 2019-09-16 | $230K | — | Filing → |